Medovate is relocating from its offices in Milton to a bigger facility in Cambridge in order to increase capacity.

Its current facility is 700 sq ft, with the new offices on Camboro Business Park measuring 6000 sq ft.

This is in line with the company beginning the commercialisation phase and launch of its medical devices across the UK, Europe and the United States

This will include SAFIRA (Safer Injection for Regional Anaesthesia), a technology to help prevent nerve damage during regional anaesthesia procedures, followed by Humidicare, a Heat and Moisture Exchanger (HME) aimed to prevent critical airway obstruction in intubated patients requiring ventilation.

Stuart Thomson, managing director, commented on the move saying: “This office relocation is the culmination of a great year for us; 2019 has seen the business go from strength to strength, with senior hires and receipt of an award naming us East of England’s most innovative medical device development company.

“As we approach 2020 there is more exciting news to come as we bring our innovative anaesthesia and critical care solutions to market. The new office will enable us to live up to our ambitious plans, providing increased levels of service for our customers, as well as giving room for further expansion as the organisation continues to grow.”